LivaNova (NSDQ:LIVN) said today it launched a new trial of its Perceval sutureless aortic valve implant in China as it pursues Chinese Registration of the device. The company claims that the lack of suturing allows the super-elastic Perceval valve to achieve optimal effective orifice area, resulting in “excellent hemodynamics.” LivaNova said procedures utilizing the Perceval valve […]
LivaNova
LivaNova finalizes details in $190m CRM sale to MicroPort
LivaNova (NSDQ:LIVN) said today it finalized the details in a deal to sell its cardiac rhythm management business to China’s MicroPort Scientific (HK:00853) in a deal worth $190 million. The companies, which are already partners in a CRM joint venture in the People’s Republic, originally announced the deal last November. London-based LivaNova said that its announcement follows “successful […]
LivaNova shares up on topped Q4, 2017 earnings
Shares in LivaNova (NSDQ:LIVN) rose today after the medical device maker met most of the expectations on Wall Street with its fourth quarter and full fiscal year 2017 earnings results. The London-based company posted losses of $111.7 million, or $2.32 per share, on sales of $278.4 million for the 3 months ended December 31, seeing losses […]
LivaNova to buy TandemLife in deal worth up to $250m
LivaNova (NSDQ:LIVN) said today it inked a deal to acquire cardiopulmonary temporary support solutions developer TandemLife in a deal worth up to $250 million. LivaNova said it will pay up to $250 million for TandemLife, with a total of $200 million in upfront costs and up to $50 million in contingent considerations based on regulatory milestones. London-based […]
LivaNova wins CE Mark for PureFlex arterial cannulae
LivaNova (NSDQ:LIVN) said yesterday it won CE Mark approval in the European Union for its PureFlex line of adult arterial cannulae. The newly cleared PureFlex cannulae are designed with curved and straight tip options and feature phthalate-free flexible tubing and a wire-reinforcement spring, the London-based company said. “Our decades-long commitment to excellence in cannulation continues with […]
UPDATE: LivaNova closes $225m ImThera buyout
Update: Altered to reflect only official details from LivaNova. LivaNova (NSDQ:LIVN) closed the $225 million buyout of ImThera Medical and its implantable sleep apnea treatment, according to an SEC filing from the company. San Diego-based ImThera’s flagship product is the Aura6000, an implanted hypoglossal nerve stimulator that uses a pair of implanted components, one near the collarbone and one […]
Cerner taps former head of Philips North America to take over corner officer | Personnel Moves January 11, 2018
Cerner Corp. (NSDQ:CERN) said yesterday that it named Brent Shafer to serve as chairman & CEO effective Feb. 1. Shafer previously served as CEO of Philips‘ (NYSE:PHG) North America business. Cerner’s co-founder Cliff Illig has been serving as interim CEO and chairman of the board since July last year. Illig said he plans to resume […]
LivaNova launches post-market study of bioprosthetic aortic heart valves
LivaNova (NSDQ:LIVN) announced today that the first patient has been enrolled in a post-market trial evaluating the overall incidence of reduced leaflet motion identified by CT imaging in patients receiving a bioprosthetic aortic heart valve. Four-dimensional CT scans will be taken of the trial’s 230 participants at least 30 days after they stop anticoagulation or dual […]
Medical device companies: These 15 performed the best in 2017
Updated Jan. 5, 2018 Among the most successful medical device companies of 2017, there were two themes: innovation and breadth of services. That was the major takeaway of an MDO analysis of the stock performance of the 100 largest publicly traded medtech companies in the world. What does innovation mean? Think Align Technology (Nasdaq:ALGN) and […]
LivaNova launches VNS treatment-resistant depression trial
LivaNova (NSDQ:LIVN) said yesterday it launched a new trial of its VNS therapy system exploring its use treating patients with treatment-resistant depression and that it enrolled the first patient in the trial. The first patient in the trial was enrolled by Karl-Jürgen Bär of Germany’s Universitätsklinikum Jena, the London-based company said. “Treatment-resistant depression, or difficult-to-treat depression, is an […]
LivaNova puts $225m on the table for ImThera Medical
LivaNova (NSDQ:LIVN) said today that it agreed to a deal for ImThera Medical and its implantable sleep apnea treatment worth $225 million. San Diego-based ImThera’s flagship product is the Aura6000, an implanted hypoglossal nerve stimulator that won FDA investigational device exemption in November 2014 for a pivotal trial. The device uses a pair of implanted components, one near the […]